Literature DB >> 34168080

Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.

Yongzhi Chen1, Xuqiu Lei1, Zhaozhao Jiang1, Katherine A Fitzgerald2.   

Abstract

Type I interferons (IFNs) are innate immune cytokines required to establish cellular host defense. Precise control of IFN gene expression is crucial to maintaining immune homeostasis. Here, we demonstrated that cellular nucleic acid-binding protein (CNBP) was required for the production of type I IFNs in response to RNA virus infection. CNBP deficiency markedly impaired IFN production in macrophages and dendritic cells that were infected with a panel of RNA viruses or stimulated with synthetic double-stranded RNA. Furthermore, CNBP-deficient mice were more susceptible to influenza virus infection than were wild-type mice. Mechanistically, CNBP was phosphorylated and translocated to the nucleus, where it directly binds to the promoter of IFNb in response to RNA virus infection. Furthermore, CNBP controlled the recruitment of IFN regulatory factor (IRF) 3 and IRF7 to IFN promoters for the maximal induction of IFNb gene expression. These studies reveal a previously unrecognized role for CNBP as a transcriptional regulator of type I IFN genes engaged downstream of RNA virus-mediated innate immune signaling, which provides an additional layer of control for IRF3- and IRF7-dependent type I IFN gene expression and the antiviral innate immune response.

Entities:  

Keywords:  CNBP; RNA virus; antiviral; transcriptional regulator; type I interferon

Mesh:

Substances:

Year:  2021        PMID: 34168080      PMCID: PMC8255963          DOI: 10.1073/pnas.2100383118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.

Authors:  Jamie M Margolis; Benedikt G Schoser; Melinda L Moseley; John W Day; Laura P W Ranum
Journal:  Hum Mol Genet       Date:  2006-04-19       Impact factor: 6.150

Review 2.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 3.  Innate immune sensing and signaling of cytosolic nucleic acids.

Authors:  Jiaxi Wu; Zhijian J Chen
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 4.  Control of adaptive immunity by the innate immune system.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2015-04       Impact factor: 25.606

5.  Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins.

Authors:  Baoyu Zhao; Chang Shu; Xinsheng Gao; Banumathi Sankaran; Fenglei Du; Catherine L Shelton; Andrew B Herr; Jun-Yuan Ji; Pingwei Li
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-02       Impact factor: 11.205

Review 6.  Myotonic dystrophy: approach to therapy.

Authors:  Charles A Thornton; Eric Wang; Ellie M Carrell
Journal:  Curr Opin Genet Dev       Date:  2017-04-01       Impact factor: 5.578

7.  Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

Authors:  Martin Schlee; Andreas Roth; Veit Hornung; Cristina Amparo Hagmann; Vera Wimmenauer; Winfried Barchet; Christoph Coch; Markus Janke; Aleksandra Mihailovic; Greg Wardle; Stefan Juranek; Hiroki Kato; Taro Kawai; Hendrik Poeck; Katherine A Fitzgerald; Osamu Takeuchi; Shizuo Akira; Thomas Tuschl; Eicke Latz; Janos Ludwig; Gunther Hartmann
Journal:  Immunity       Date:  2009-07-02       Impact factor: 31.745

8.  Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice.

Authors:  Hideyuki Yanai; Shiho Chiba; Sho Hangai; Kohei Kometani; Asuka Inoue; Yoshitaka Kimura; Takaya Abe; Hiroshi Kiyonari; Junko Nishio; Naoko Taguchi-Atarashi; Yu Mizushima; Hideo Negishi; Rudolf Grosschedl; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

Review 9.  Evasion of early antiviral responses by herpes simplex viruses.

Authors:  Paula A Suazo; Francisco J Ibañez; Angello R Retamal-Díaz; Marysol V Paz-Fiblas; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Mediators Inflamm       Date:  2015-03-30       Impact factor: 4.711

Review 10.  Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.

Authors:  Annsea Park; Akiko Iwasaki
Journal:  Cell Host Microbe       Date:  2020-05-27       Impact factor: 21.023

View more
  2 in total

1.  CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates.

Authors:  Katherine Fitzgerald; Yongzhi Chen; Xuqiu Lei; Zhaozhao Jiang; Fiachra Humphries; Nicholas Mustone; Irene Ramos; Tinaye Mutetwa; Ana Fernandez-Sesma
Journal:  Res Sq       Date:  2022-05-02

2.  Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders.

Authors:  Christian Scheiber; Tanja Schulz; Julian M Schneider; Karl Bechter; E Marion Schneider
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.